Zifi 100 Readymix Oral Suspension contains Cefixime 100mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The ready-to-use oral suspension formulation facilitates accurate dosing and improved patient compliance, particularly in pediatric and geriatric populations. Zifi 100 should be administered as prescribed, typically twice daily, with or without food. Dosage adjustments may be necessary in patients with renal impairment. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions are rare but may occur. It is contraindicated in patients with known allergy to cephalosporins or penicillins. Use during pregnancy and lactation should be under medical supervision. Proper adherence to the prescribed course is essential to prevent the development of antibiotic resistance. Storage should be at controlled room temperature, and the suspension should be shaken well before use. Consult a healthcare professional before initiating therapy with Zifi 100 Readymix Oral Suspension.